Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Comment
  • Published:

Legacy data sharing to improve drug safety assessment: the eTOX project

Abstract

The sharing of legacy preclinical safety data among pharmaceutical companies and its integration with other information sources offers unprecedented opportunities to improve the early assessment of drug safety. Here, we discuss the experience of the eTOX project, which was established through the Innovative Medicines Initiative to explore this possibility.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

References

  1. Obiol-Pardo, C. et al. A multiscale simulation system for the prediction of drug-induced cardiotoxicity. J. Chem. Inf. Model. 51, 483–492 (2011).

    Article  CAS  Google Scholar 

  2. Carbonell, P. et al. Hepatotoxicity prediction by systems biology modeling of disturbed metabolic pathways using gene expression data. ALTEX 34, 219–234 (2017)10.14573/altex.1602071.

    Article  PubMed  Google Scholar 

  3. Harvey, J. et al. Management of organic impurities in small molecule medicinal products: deriving safe limits for use in early development. Regul. Toxicol. Pharmacol. 84, 116–123 (2017)10.1016/j.yrtph.2016.12.011.

    Article  CAS  PubMed  Google Scholar 

  4. Carrió, P. et al. Applicability Domain Analysis (ADAN): a robust method for assessing the reliability of drug property predictions. J. Chem. Inf. Model. 54, 1500–1511 (2014).

    Article  Google Scholar 

  5. Hewitt, M. et al. Ensuring confidence in predictions: a scheme to assess the scientific validity of in silico models. Adv. Drug Deliv. Rev. 86, 101–111 (2015)10.1016/j.addr.2015.03.005.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Corresponding authors

Correspondence to Ferran Sanz or François Pognan.

Ethics declarations

Competing interests

Some of the authors are employed in the pharmaceutical industry or in small and medium-sized enterprises, as indicated in the author affliations.

Supplementary information

Supplementary information S1 (box)

eTOX-related web sites and publications (PDF 173 kb)

Related links

Related links

FURTHER INFORMATION

eTOX

eTOXlab

eTOXsys

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sanz, F., Pognan, F., Steger-Hartmann, T. et al. Legacy data sharing to improve drug safety assessment: the eTOX project. Nat Rev Drug Discov 16, 811–812 (2017). https://doi.org/10.1038/nrd.2017.177

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd.2017.177

This article is cited by

Search

Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research